Serum HER-2/neu extracellular domain levels in men presenting with suspected prostate cancer

UroOncology

Volumn 2, Issue 2, 2002, Pages 99-102

  Croal, B L ^a,b,c   Mitchell, I D C ^a   Mutch, W J ^a   Dickie, A ^a   Cohen, N ^a   Ross, I S ^a  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c NONE   (United Kingdom)

Author keywords

HER 2 neu; Oncogene; Prostate cancer; PSA

Indexed keywords

GENE PRODUCT; ONCOPROTEIN; PROSTATE SPECIFIC ANTIGEN;

ADVANCED CANCER; ARTICLE; AUTOANALYZER; BREAST CANCER; CONTROLLED STUDY; DISEASE COURSE; EARLY CANCER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; ONCOGENE NEU; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN DOMAIN;

EID: 0036625856     PISSN: 15610950     EISSN: None     Source Type: Journal    
DOI: 10.1080/1561095021000011936     Document Type: Article

References (26)

1. Zabrecky, J.R., Lam, T., McKenzie, S.J. and Carney, W. (1991) "The extracellular domain of p185/neu is released from the surface of human breast carcinoma cells, SK-BR-3", J. Biol. Chem. 266, 1716-1720.
2. Kandhl, H., Seymour, L. and Bezwoda, W.R. (1994) "Soluble c-erbB-2 fragment in serum correlates with disease stage and predicts for shortened survival in patients with early-stage and advanced breast cancer", Br. J. Cancer 70, 739-742.
3. Brandt-Rauf, P.W., Pincus, M.R. and Carney, W.P. (1994) "The c-erbB-2 protein in oncogenesis: Molecular structure to molecular epidemiology", Crit. Rev. Oncog. 5, 313-329.
4. Kraus, M.H., Popescu, N.C., Amsbaugh, S.C. and King, C.R. (1987) "Overexpression of the EGF-receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms", EMBO J. 6, 605-610.
5. Kath, R., Hoffken, K., Otte, C., Metz, K., Scheulen, M.E., Hulskamp, F. and Seeber, S. (1993) "The neu oncogene product in serum and tissue of patients with breast carcinoma", Ann. Oncol. 4, 585-590.
6. Isola, J.J., Holli, K., Oksa, H., Teramoto, Y. and Kallioniemi, O.P. (1994) "Elevated erbB-2 oncogene protein levels in preoperative and follow-up serum samples define an aggressive disease course in patients with breast cancer", Cancer 73, 652-658.
7. Slamon, D.J., Godolphin, W., Jones, L.A., Holt, J.A., Wong, S.G., Keith, D.E., Levin, W.J., Stuart, S.G., Udove, J. and Ullrich, A. (1989) "Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer", Science 244, 707-712.
8. Yonemura, Y., Nimomiya, I., Yamaguchi, A., Fushida, S., Kimura, H., Ohoyama, S., Miyazaki, I., Endou, Y., Tanaka, M. and Sasaki, T. (1991) "Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short-term prognosis in gastric cancer", Cancer Res. 51, 1034-1038.
9. Berchuk, A., Rodriguez, G., Kinney, R.B., Soper, J.T., Dodge, R.K., Clarke-Pearson, D.L. and Bast, R.C. Jr. (1991) "Overexpression of HER-2/neu in endometrial cancer is associated with advanced stage disease", Am. J. Obstet. Gynecol. 164, 15-21.
10. Press, M.F., Pike, M.C., Hung, G., Zhou, J.Y., Ma, Y., George, J., Dietz-Band, J., James, W., Slamon, D.J. and Batsakis, J.G. (1994) "Amplification and overexpression of HER-2/neu carcinomas of the salivary gland: correlation with poor prognosis", Cancer 54, 5675-5682.
11. Brandt-Rauf, P. and Luo, J.C. (1994) "Detection and increased amounts of the extracellular domain of the c-erbB-2 oncoprotein in serum during pulmonary carcinogenesis in humans", Int. J. Cancer 56, 383-386.
12. Yang, J.L., Yu, Y., Markovic, B., Russel, P.J. and Crowe, P.J. (1997) "Overexpression of c-erbB-2 mRNA and/or c-neu oncoprotein is a predictor for metastases from colorectal cancer", Tumor Biol. 17, 1023-1026.
13. Okada, N., Ohshio, G., Yamaki, K., Imamura, T. and Imamura, M. (1995) "Elevated serum c-erbB-2 protein levels in patients with pancreatic cancer: Correlation to metastasis and shorter survival", Oncology 52, 392-396.
14. Myers, R.B., Srivastava, S., Oelschlager, D.K. and Grissle, W.E. (1995) "Serum levels of erbB-2 protein in patients with prostatic adenocarcinoma [Abstract]", Proc. Am. Assoc. Cancer Res. 36, 645.
15. Sadasivan, R., Morgan, R., Jennings, S., Austenfeld, M., Van Veldhuizen, P., Stephens, R. and Noble, M. (1993) "Overexpression of HER-2/neu may be an indicator of poor prognosis in prostate cancer", J. Urol. 150, 126-131.
16. Ross, J.S., Sheehan, C., Hayner-Buchan, A.M., Ambros, R.A., Kallakury, B.V., Kaufman, R., Fisher, H.A. and Muraca, P.J. (1997) "HER-2/neu gene amplification status in prostate cancer by fluorescence in situ hybridization", Hum. Pathol. 28, 827-833.
17. Ross, J.S., Sheehan, C.E., Hayner-Buchan, A.M., Ambros, R.A., Kallakury, B.V., Kaufman, R.P., Fisher, H.A., Rifkin, M.D. and Muraca, P.J. (1997) "Prognostic significance of HER-2/neu gene amplification status by fluorescence in situ hybridization of prostate carcinoma", Cancer 79, 2162-2170.
18. Mydlo, J.H., Kral, J.G., Volpe, M., Axotis, C., Macchia, R.J. and Pertschuk, L.P. (1998) "An analysis of microvessel density, androgen receptor, p53 and HER-2/neu expression and Gleason score in prostate cancer: Preliminary results and therapeutic implications", Eur. Urol. 34, 426-432.
19. Gu, K., Mes-Masson, A.M., Gauthier, J. and Saad, F. (1996) "Overexpression of her-2/neu in human prostate cancer and benign prostatic hyperplasia", Cancer Lett. 99, 185-189.
20. Craft, N., Shostak, Y., Carey, M. and Sawyers, C.L. (1999) "A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase", Nature Med. 5, 280-285.
21. Payne, R.C., Allard, J.W., Anderson-Mauser, L., Humphreys, J.D., Tenney, D.Y. and Morris, D.L. (2000) "Automated assay for HER-2/neu in serum", Clin. Chem. 46, 175-182.
22. Molina, R., Jo, J., Zanon, G., Filella, X., Farrus, B., Munoz, M., Latre, M.L., Pahisa, J., Velasco, M., Fernandez, P., Estape, J. and Ballesta, A.M. (1996) "Utility of C-erbB-2 in tissue and in serum in the early diagnosis of recurrence in breast cancer patients: Comparison with carcinoembryonic antigen and CA15.3", Int. J. Cancer 74, 1126-1131.
23. Yamauchi, H., O'Neill, A., Gelman, R., Carney, W., Tenney, D.Y., Hosch, S. and Hayes, D. (1997) "Prediction of response to antiestrogen therapy in advanced breast cancer patients by pretreatment circulating levels of extracellular domain of the HER-2/neu protein", J. Clin. Oncol. 15, 2518-2525.
24. Leitzel, K., Teramoto, Y., Konrad, K., Chinchilli, V.M., Volas, G., Grossberg, H., Harvey, H., Demers, L. and Lipton, A. (1995) "Elevated serum c-erbB-2 antigen levels and decreased response to hormone therapy of breast cancer", J. Clin. Oncol. 13, 1129-1135.
25. Stamey, T.A. (1995) "Making the most out of six systematic sextant biopsies", Urology 45, 2.
26. Neaman, I.E., Goldblatt, J.L., Cook, G.B., Bruzek, D., Smith, C., Morris, D.L., Schwartz, M.K., Chan, D.W. and Allard, W.J. (2000) "Multicenter evaluation of the analytical performance of the Bayer Immuno-1 HER-2/neu Assay", Clin. Chem. 46(6).